Evidence map›Paper›PMID 32481686›Full record

ArticleNutrients2020

Michele Campitelli, Antonella Desiderio, Giuseppe Cacace, Cecilia Nigro, Immacolata Prevenzano, Alessia Leone, Sonia de Simone, Pietro Campiglia, Pietro Formisano, Gregory A Raciti and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Anti-Obesity Effects of a Mixture ofMolecules (Basel, Switzerland) · 2022
    Article
  2. Nutrients · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Michele CampitelliURT Genomics of Diabetes, Institute of Experimental Endocrinology and Oncology, National Research Council, 80131 Naples, Italy.
Antonella DesiderioURT Genomics of Diabetes, Institute of Experimental Endocrinology and Oncology, National Research Council, 80131 Naples, Italy.
Giuseppe CacaceURT Genomics of Diabetes, Institute of Experimental Endocrinology and Oncology, National Research Council, 80131 Naples, Italy.
Cecilia NigroURT Genomics of Diabetes, Institute of Experimental Endocrinology and Oncology, National Research Council, 80131 Naples, Italy.
Immacolata PrevenzanoURT Genomics of Diabetes, Institute of Experimental Endocrinology and Oncology, National Research Council, 80131 Naples, Italy.
Alessia LeoneURT Genomics of Diabetes, Institute of Experimental Endocrinology and Oncology, National Research Council, 80131 Naples, Italy.
Sonia de SimoneURT Genomics of Diabetes, Institute of Experimental Endocrinology and Oncology, National Research Council, 80131 Naples, Italy.
Pietro CampigliaDepartment of Pharmacy, University of Salerno, 84084 Fisciano, Italy.ORCID 0000-0002-1069-2181
Pietro FormisanoURT Genomics of Diabetes, Institute of Experimental Endocrinology and Oncology, National Research Council, 80131 Naples, Italy.
Gregory A RacitiURT Genomics of Diabetes, Institute of Experimental Endocrinology and Oncology, National Research Council, 80131 Naples, Italy.
Francesco BeguinotURT Genomics of Diabetes, Institute of Experimental Endocrinology and Oncology, National Research Council, 80131 Naples, Italy.
Claudia MieleURT Genomics of Diabetes, Institute of Experimental Endocrinology and Oncology, National Research Council, 80131 Naples, Italy.
Institute for Experimental Endocrinology and Oncology · ITUniversity of Salerno · IT

Funding

Consiglio Nazionale delle Ricerche FLAGSHIP Interomics Project ASPIREEuropean Foundation for the Study of Diabetes Boehringer Ingelheim (2018-2020).Italian Diabete Ricerca Foundation and Eli Lilly Italy 2018-2020Ministero dell'Istruzione, dell'Università e della Ricerca PON "RICERCA E INNOVAZIONE" 2014 - 2020 E FSC - progetto "Innovative Devices For SHAping the RIsk of Diabetes" (IDF SHARID) - ARS01_01270Ministero dell'Istruzione, dell'Università e della Ricerca PRIN 2017Regione Campania POR FESR 2014-2020 - Obiettivo specifico 1.2. - Manifestazione di Interesse per la Realizzazione di Technology Platform nell'ambito della Lotta alle Patologie Oncologiche" - Projects COEPICA, RARE PLAT NET and SATIN
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

3T3 CellsAdipocytesAdipogenesisAnimalsCCAAT-Enhancer-Binding Protein-betaCell DifferentiationCitrusCREB-Binding ProteinDown-RegulationGene ExpressionMiceMicroRNAsPlant ExtractsRNA, MessengerTumor Necrosis Factor-alphaCCAAT-Enhancer-Binding Protein-betaCREB-Binding ProteinCrebbp protein, mouseMicroRNAsMirn155 microRNA, mousePlant ExtractsRNA, MessengerTumor Necrosis Factor-alphaadipogenesisCitrus aurantium L. dry extractsmiR-155tumor necrosis factor-alpha

Identifiers

PMID32481686
PMCPMC7352926
OpenAlexW3029681210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.